ST. PAUL, Minn., Aug. 2, 2017 /PRNewswire/ -- EnteroMedics
Inc. (NASDAQ:ETRM), a developer of minimally invasive medical
devices to treat obesity, metabolic diseases and other
gastrointestinal disorders today announced that it will host a
conference call to discuss strategic business updates and financial
results for the second quarter of 2017 on Tuesday, August 8, 2017 at 11:30 AM Eastern Time.
Individuals interested in listening to the conference call may
do so by dialing (877) 280-7473 for domestic callers or (707)
287-9370 for international callers, using Conference ID: 64730754.
To access the live webcast or replay, please visit the events page
of the investor relations section of the EnteroMedics website at:
http://ir.enteromedics.com.
About EnteroMedics Inc.
EnteroMedics is a medical device company focused on the
development and commercialization of technology to treat obesity
and metabolic diseases. vBloc® Neurometabolic Therapy, delivered by
an FDA-approved pacemaker-like device called the vBloc® System, is
designed to help patients feel full and eat less by intermittently
blocking hunger signals on the vagus nerve. EnteroMedics recently
acquired the Gastric Vest System™ through its acquisition of
BarioSurg, Inc. The Gastric Vest is an investigational, minimally
invasive, laparoscopically implanted medical device being studied
for weight loss in morbidly obese patients. The device wraps around
the stomach, emulating the effect of conventional weight-loss
surgery, and is intended to enable gastric volume reduction without
permanently changing patient anatomy.
Sign up for EnteroMedics investor alerts and news at
http://ir.enteromedics.com/alerts.cfm.
View original content with
multimedia:http://www.prnewswire.com/news-releases/enteromedics-to-discuss-business-strategy-and-financial-results-for-the-second-quarter-of-2017-300498091.html
SOURCE EnteroMedics Inc.